These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30680696)

  • 1. Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP.
    Bennett D; Salvini M; Fui A; Cillis G; Cameli P; Mazzei MA; Fossi A; Refini RM; Rottoli P
    Inflammation; 2019 Apr; 42(2):463-470. PubMed ID: 30680696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calgranulin B (S100A9/MRP14): a key molecule in idiopathic pulmonary fibrosis?
    Bargagli E; Olivieri C; Cintorino M; Refini RM; Bianchi N; Prasse A; Rottoli P
    Inflammation; 2011 Apr; 34(2):85-91. PubMed ID: 20422274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.
    Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T
    Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Role of Bronchoalveolar Lavage in the Diagnosis of Idiopathic Pulmonary Fibrosis: An Investigation of the Relevance of the Protein Content].
    Schildge J; Frank J; Klar B
    Pneumologie; 2016 Jul; 70(7):435-41. PubMed ID: 27218212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
    Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases.
    Papanikolaou IC; Boki KA; Giamarellos-Bourboulis EJ; Kotsaki A; Kagouridis K; Karagiannidis N; Polychronopoulos VS
    Immunol Lett; 2015 Feb; 163(2):179-86. PubMed ID: 25540922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of S100A9 and KL-6 in common interstitial lung diseases.
    Lin L; Zhao Y; Li Z; Li Y; Wang W; Kang J; Wang Q
    Medicine (Baltimore); 2022 Apr; 101(17):e29198. PubMed ID: 35512076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.
    Veeraraghavan S; Latsi PI; Wells AU; Pantelidis P; Nicholson AG; Colby TV; Haslam PL; Renzoni EA; du Bois RM
    Eur Respir J; 2003 Aug; 22(2):239-44. PubMed ID: 12952254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-13 and its receptors in idiopathic interstitial pneumonia: clinical implications for lung function.
    Park SW; Ahn MH; Jang HK; Jang AS; Kim DJ; Koh ES; Park JS; Uh ST; Kim YH; Park JS; Paik SH; Shin HK; Youm W; Park CS
    J Korean Med Sci; 2009 Aug; 24(4):614-20. PubMed ID: 19654941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
    Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S
    Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A non-invasive equation in diagnosis of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia].
    Lü CJ; Li HB; Wang XZ; Li YY; Zhang XR; Wang G
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):376-9. PubMed ID: 20646408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis.
    Bennett D; Bargagli E; Bianchi N; Landi C; Fossi A; Fui A; Sestini P; Refini RM; Rottoli P
    Respir Physiol Neurobiol; 2020 Feb; 273():103323. PubMed ID: 31678459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
    Barisione G; Brusasco C; Garlaschi A; Baroffio M; Brusasco V
    J Appl Physiol (1985); 2016 May; 120(9):1029-38. PubMed ID: 26893034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors.
    Korfei M; von der Beck D; Henneke I; Markart P; Ruppert C; Mahavadi P; Ghanim B; Klepetko W; Fink L; Meiners S; Krämer OH; Seeger W; Vancheri C; Guenther A
    J Proteomics; 2013 Jun; 85():109-28. PubMed ID: 23659799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients.
    Vercauteren IM; Verleden SE; McDonough JE; Vandermeulen E; Ruttens D; Lammertyn EJ; Bellon H; De Dycker E; Dooms C; Yserbyt J; Verleden GM; Vanaudenaerde BM; Wuyts WA
    Exp Lung Res; 2015; 41(8):459-65. PubMed ID: 26381718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.
    Okamoto T; Fujii M; Furusawa H; Tsuchiya K; Miyazaki Y; Inase N
    Respir Med; 2015 Dec; 109(12):1576-81. PubMed ID: 26481343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible role of galectin-9 in the pulmonary fibrosis of patients with interstitial pneumonia.
    Matsumoto N; Katoh S; Yanagi S; Arimura Y; Tokojima M; Ueno M; Hirashima M; Nakazato M
    Lung; 2013 Apr; 191(2):191-8. PubMed ID: 23321864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.